These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 27838408)
21. Comparative evaluation of two immunoassays for cerebrospinal fluid β-Amyloid Zecca C; Brescia V; Piccininni M; Capozzo R; Barone R; Barulli MR; Logroscino G Clin Chim Acta; 2019 Jun; 493():107-111. PubMed ID: 30844363 [TBL] [Abstract][Full Text] [Related]
22. Automated measurement of 25-OH Vitamin D on the LUMIPULSE Parra M; Foj L; Filella X Br J Biomed Sci; 2016 Jul; 73(3):104-109. PubMed ID: 27310165 [TBL] [Abstract][Full Text] [Related]
23. Assessment of the Concordance and Diagnostic Accuracy Between Elecsys and Lumipulse Fully Automated Platforms and Innotest. Dakterzada F; López-Ortega R; Arias A; Riba-Llena I; Ruiz-Julián M; Huerto R; Tahan N; Piñol-Ripoll G Front Aging Neurosci; 2021; 13():604119. PubMed ID: 33746733 [TBL] [Abstract][Full Text] [Related]
24. Analytical evaluation of point-of-care procalcitonin (PCT) and clinical performances in an unselected population as compared with central lab PCT assay. Dupuy AM; Chevrier Q; Olejnik Y; Bargnoux AS; Badiou S; Cristol JP Clin Chem Lab Med; 2017 Jul; 55(8):e167-e171. PubMed ID: 27987361 [No Abstract] [Full Text] [Related]
25. Krebs von den Lungen-6 as Disease Severity Marker for COVID-19 Patients: Analytical Verification and Quality Assessment of the Tosoh AIA-360 Compared to Lumipulse G600II. d'Alessandro M; Bergantini L; Cavallaro D; Gangi S; Cameli P; Conticini E; Siena Covid Unit ; Frediani B; Dotta F; Bargagli E Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206372 [TBL] [Abstract][Full Text] [Related]
26. Evaluation of a new procalcitonin assay for the Siemens ADVIA Centaur with the established method on the B.R.A.H.M.S Kryptor. Sanders RJ; Schoorl M; Dekker E; Snijders D; Boersma WG; Ten Boekel E Clin Lab; 2011; 57(5-6):415-20. PubMed ID: 21755834 [TBL] [Abstract][Full Text] [Related]
27. A new strategy for the development of monoclonal antibodies for the determination of human procalcitonin in serum samples. Kremmer E; Meyer K; Grässer FA; Flatley A; Kösters M; Luppa PB; Krämer PM Anal Bioanal Chem; 2012 Jan; 402(2):989-95. PubMed ID: 22006244 [TBL] [Abstract][Full Text] [Related]
28. Reply to: Analytical evaluation of the performances of Diazyme and BRAHMS procalcitonin applied to Roche Cobas in comparison with BRAHMS PCT-sensitive Kryptor. Yuan C Clin Chem Lab Med; 2017 Nov; 56(1):e5-e6. PubMed ID: 29031019 [No Abstract] [Full Text] [Related]
29. Analytical Evaluation of Point-of-Care Finecare™ Procalcitonin Rapid Quantitative Test in Sepsis Population as Compared with Elecsys Mazlan MZ; Wan Azman WN; Yaacob NM; Koon TS; Yahya NK Diagnostics (Basel); 2024 May; 14(11):. PubMed ID: 38893607 [TBL] [Abstract][Full Text] [Related]
30. Multicenter evaluation of a new immunoassay for procalcitonin measurement on the Kryptor System. Steinbach G; Rau B; Debard AL; Javourez JF; Bienvenu J; Ponzio A; Bonfà A; Hubl W; Demant T; Külpmann WR; Buchholz J; Schumann G Clin Chem Lab Med; 2004 Apr; 42(4):440-9. PubMed ID: 15147156 [TBL] [Abstract][Full Text] [Related]
31. [Determination of procalcitonin (PCT) in micro-method on AQT90 FLEX® analyzer and in vitro stability study]. Mine L; Petit M; Nivet-Antoine V; Beaudeux JL; Hennequin C Ann Biol Clin (Paris); 2018 Jan; 76(1):53-59. PubMed ID: 29199155 [TBL] [Abstract][Full Text] [Related]
32. Analytical evaluation of the novel soluble fms-like tyrosine kinase 1 and placental growth factor assays for the diagnosis of preeclampsia. van Helden J; Weiskirchen R Clin Biochem; 2015 Nov; 48(16-17):1113-9. PubMed ID: 26129879 [TBL] [Abstract][Full Text] [Related]
33. Evaluation of procalcitonin immunoassay concordance near clinical decision points. Chambliss AB; Hayden J; Colby JM Clin Chem Lab Med; 2019 Aug; 57(9):1414-1421. PubMed ID: 30763263 [TBL] [Abstract][Full Text] [Related]
34. Development of a novel chemiluminescence immunoassay for the detection of procalcitonin. Wang G; Wan Y; Lin G; Li Z; Dong Z; Liu T J Immunol Methods; 2020; 484-485():112829. PubMed ID: 32673618 [TBL] [Abstract][Full Text] [Related]
35. A new sensitive automated assay for procalcitonin detection: LIAISON Fortunato A Pract Lab Med; 2016 Dec; 6():1-7. PubMed ID: 28856207 [TBL] [Abstract][Full Text] [Related]
36. Comparison of the Abbott Architect BRAHMS and the Biomérieux Vidas BRAHMS Procalcitonin Assays. Wang D; Caddell B; Nolte FS; Babic N J Appl Lab Med; 2019 Jan; 3(4):580-586. PubMed ID: 31639727 [TBL] [Abstract][Full Text] [Related]
37. Validation of the procalcitonin (PCT) assay: Experience in a pediatric hospital. Agarwal S; Akbas N; Soundar EP; Gonzalez G; Devaraj S Clin Biochem; 2015 Sep; 48(13-14):886-90. PubMed ID: 25895483 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of Lumipulse® G1200 for the measurement of six tumor markers: Comparison with AIA® 2000. de Rancher MR; Oudart JB; Maquart FX; Monboisse JC; Ramont L Clin Biochem; 2016 Nov; 49(16-17):1302-1306. PubMed ID: 27521619 [TBL] [Abstract][Full Text] [Related]
39. Evaluation of procalcitonin with liquid-phase binding assay in hematological malignancy. Koya J; Nannya Y; Kurokawa M Clin Chim Acta; 2012 Oct; 413(19-20):1633-6. PubMed ID: 22579768 [TBL] [Abstract][Full Text] [Related]
40. Analytical evaluation and bioclinical validation of new aldosterone and renin immunoassays. Coulon C; Lotierzo M; Fesler P; Roubille C; Badiou S; Dupuy AM; Cristol JP Clin Chem Lab Med; 2022 Oct; 60(11):1763-1771. PubMed ID: 36096492 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]